Bixiye
P29-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Members – eviCore Healthcare Utilization Management Program
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Natiijooyinka Raadinta
Soo bandhiga 1931 - 1940 ee natiijooyinka 4233
Bixiye
P24-19 Blue Cross to Decommission Legacy Claims System
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
QP20-19 Pharmacy Benefit Exclusion for Ultomiris (ravulizumab-cwvz) IV Injection
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
QP22-19 Pharmacy Benefit Update - New Drug-Related Step Therapy Criteria: Methotrexate Injectable
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2019
Bixiye
QP18-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Sucralfate Suspension
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2019
Bixiye
QP16-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Orilissa (elagolix)
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2019
Bixiye
QP19-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Galafold (migalastat)
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2019
Bixiye
QP21-19 Reminder: Blue Cross Vision Plans with the Davis Vision Network
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2019
Bixiye
2019 March Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2019
Bixiye
QP8-19 Addition of Drugs to the Oral Tetracycline Derivatives Prior Authorization Program
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019